ARCHIVES

Perjeta, Herceptin & Docetaxel Combination Extended Survival in HER2-Positive Disease

This article is from The Cancer Letter archive.

Vol. 35 No. 12 | December 28, 2012

Download PDF Visit The Full Archive

Related Articles

CMS Withholds Coverage of CT Colonography

May 15, 2009

Ad Council, ACS Begin Ad Campaign To Promote Colon Cancer Screening.

February 1, 2002

Cancer Panel To Examine Health Of Phase I Trials

May 17, 1996

DCPC Advisors Okay Continuation of Children’s Diet Study

January 31, 1992

Garfinkel to Retire From ACS; Health to Succeed Him

July 20, 1990

Four More COP Awards Announced

January 9, 1981